Lipid Nanoparticles for <i>In Vivo</i> Lung Delivery of CRISPR-Cas9 Ribonucleoproteins Allow Gene Editing of Clinical Targets

Authors: Rebecca M. Haley, Marshall S. Padilla, Rakan D. El-Mayta, Ryann A. Joseph, Jesse A. Weber, Christian G. Figueroa-Espada, Alvin J. Mukalel, Adele S. Ricciardi, Rohan Palanki, Hannah C. Geisler, Matthew T. Jester, Beverly L. Davidson, Michael J. Mitchell

Published: 2025-04-04

DOI: 10.1021/acsnano.4c16617

Source: Full article


Abstract

No abstract found.